newsfilter
← Latest News
GlobeNewswire·

Clarus Therapeutics to Report Fourth Quarter and Full Year 2021 Financial and Operating Results

NORTHBROOK, Ill., March 29, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. ("Clarus") (NASDAQ:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and